To do so, we assessed S1-S3 signature17, stem cell signature18, EpCAM signature19, Metastatic signature20, CCA-like signature21, Cluster 2 signature22, proliferation signature23 and found a concordance between the good and poor survival subclasses defined by the metabolic genes and those defined by published signatures. Here, EPCAM is linked to cholangiocarcinoma.